Historical record - last NADAC effective date: 10/18/2023
Product Information
FENOFIBRATE 54 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0946 per EA under NDC 43598090990. Its NADAC has been published 182 times since May 13, 2020.
FDA first approved this application on Sep 6, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the FENOFIBRATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
54 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598090990
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/18/2023
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA210670FDA Approved
9/6/2019
TE Code
AB
On Market Since
1/31/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 54 MG TABLET has been published 182 times since May 13, 2020, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0946 per EA |
|---|---|
| All-time high | $0.2281 (Nov 11, 2020) |
| All-time low | $0.0946 (Oct 18, 2023) |
| Median price | $0.1379 |
| Average price | $0.1414 |
| Largest weekly change | -23.1% (Nov 18, 2020) |
| Weeks tracked | 182 |
| Tracking since | May 13, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-1.5%
5Y
-34.6%
All
-52.1%
Last surveyed Nov 1, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 54 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 54 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0946 per EA (NDC 43598090990), effective Nov 1, 2023.
How has the price of FENOFIBRATE 54 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 54 MG TABLET has declined 52.1%. It has been tracked across 182 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 54 MG TABLET?
Since May 13, 2020, the NADAC for FENOFIBRATE 54 MG TABLET has ranged from a low of $0.0946 (Oct 18, 2023) to a high of $0.2281 (Nov 11, 2020), with a median of $0.1379 per EA.
Are there cheaper alternatives to FENOFIBRATE 54 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 54 MG TABLET, is $0.0779 per EA — about 18% below FENOFIBRATE 54 MG TABLET.
Who manufactures FENOFIBRATE 54 MG TABLET?
FENOFIBRATE 54 MG TABLET (NDC 43598090990) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.